Literature DB >> 20415819

Psoriatic arthritis.

Uwe Wollina1, Leonore Unger, Birgit Heinig, Thomas Kittner.   

Abstract

Psoriatic arthritis (PSA) is an entity of inflammatory joint disease associated with psoriasis. PSA belongs to the heterogeneous group of seronegative spondylarthropathies. Both peripheral joints and axial skeleton can be affected in a characteristic pattern. In addition to that, enthesitis and dactylitis are important extracutaneous manifestations. Uveitis anterior is temporarily seen in about one quarter of PSA patients. There is a closer relationship of nail and joint disease. This review provides data on drug and physical treatment options. In particular DMARDS and inhibitors of tumor necrosis factor alpha are established therapies with importance for quality of life and long term outcome. New drugs are tested in various trials.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20415819     DOI: 10.1111/j.1529-8019.2010.01306.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  8 in total

1.  [Psoriasis arthritis. An interdisciplinary challenge].

Authors:  M A Radtke; K Reich; F Beikert; M Augustin
Journal:  Hautarzt       Date:  2011-10       Impact factor: 0.751

2.  Test yourself: answer psoriatic onycho-pachydermo periostitis (POPP).

Authors:  Sarath Bethapudi; Jill Halstead; Zoe Ash; Dennis McGonagle; Andrew J Grainger
Journal:  Skeletal Radiol       Date:  2014-03       Impact factor: 2.199

3.  A Rapidly Progressive Variant of Psoriatic Arthritis: Psoriatic Onycho-Pachydermo-Periostitis.

Authors:  Sibel Süzen Özbayrak; Vildan Binay Safer; Mustafa Özbayrak
Journal:  Arch Rheumatol       Date:  2016-03-22       Impact factor: 1.472

Review 4.  The Diagnosis and Treatment of Nail Disorders.

Authors:  Uwe Wollina; Pietro Nenoff; Gunter Haroske; Holger A Haenssle
Journal:  Dtsch Arztebl Int       Date:  2016-07-25       Impact factor: 5.594

5.  Economic Evaluation of Timely Versus Delayed Use of Tumor Necrosis Factor Inhibitors for Treatment of Psoriatic Arthritis in the US.

Authors:  Vibeke Strand; Elaine Husni; Jenny Griffith; Zheng-Yi Zhou; James Signorovitch; Arijit Ganguli
Journal:  Rheumatol Ther       Date:  2016-09-15

6.  Fumaric acid esters in dermatology.

Authors:  Uwe Wollina
Journal:  Indian Dermatol Online J       Date:  2011-07

Review 7.  Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives.

Authors:  Anna Campanati; Veronica Consales; Monia Orciani; Katia Giuliodori; Giulia Ganzetti; Ivan Bobyr; Giulia Sorgentoni; Roberto di Primio; Annamaria Offidani
Journal:  Psoriasis (Auckl)       Date:  2017-11-27

Review 8.  Psoriatic arthritis and COVID-19 pandemic: Consequences in medical treatment?

Authors:  Uwe Wollina; Massimo Fioranelli; Mohamad Goldust; Torello Lotti
Journal:  Dermatol Ther       Date:  2020-06-30       Impact factor: 3.858

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.